Correction: A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines

Correction: A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552792/?tool=EBI

Similar Items

Correction: A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines.
by: Albert Jan van Hoek, et al.
Published: (2012-01-01)

Comparative Analysis of G1P[8] Rotaviruses Identified Prior to Vaccine Implementation in Pakistan With Rotarix™ and RotaTeq™ Vaccine Strains
by: Asma Sadiq, et al.
Published: (2020-10-01)

Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalisations in Brazil
by: Antoine Chaouki El Khoury, et al.
Published: (2011-08-01)

G2P[4]-RotaTeq Reassortant Rotavirus in Vaccinated Child, United States
by: Sunando Roy, et al.
Published: (2015-11-01)

Differences in the amino acid composition of the antigen epitopes of the VP7 protein of Russian rotaviruses with the G9 genotype and the vaccine strains RotaTeq, Rotavac, and Rotarix
by: O. V. Morozova, et al.
Published: (2019-05-01)

Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008–2016
by: Penina Haber, et al.
Published: (2018-11-01)

One-step multiplex real-time RT-PCR assay for detecting and genotyping wild-type group A rotavirus strains and vaccine strains (Rotarix® and RotaTeq®) in stool samples
by: Rashi Gautam, et al.
Published: (2016-01-01)

Genomic Analysis of Rwandan G9P[8] Rotavirus Strains Pre- and Post-RotaTeq<sup>®</sup> Vaccine Reveals Significant Distinct Sub-Clustering in a Post-Vaccination Cohort
by: Robyn-Lee Potgieter, et al.
Published: (2023-11-01)

Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.
by: Frédéric Debellut, et al.
Published: (2020-01-01)

The evolving epidemiology of rotavirus A infection in Brazil a decade after the introduction of universal vaccination with Rotarix®
by: Filipe A. Carvalho-Costa, et al.
Published: (2019-01-01)

Monitoring the circulation of rotavirus among children after the introduction of the RotarixTM vaccine in Goiânia, Brazil
by: Ana Maria Tavares Borges, et al.
Published: (2011-06-01)

Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction.
by: Innocent Mwape, et al.
Published: (2017-01-01)

Comparative analysis of the Rotarix™ vaccine strain and G1P[8] rotaviruses detected before and after vaccine introduction in Belgium
by: Mark Zeller, et al.
Published: (2017-01-01)

Shedding of porcine circovirus type 1 DNA and rotavirus RNA by infants vaccinated with Rotarix®
by: Slavica Mijatovic-Rustempasic, et al.
Published: (2017-04-01)

RIX4414 (Rotarix™): uma vacina contra o rotavírus humano com vírus vivo atenuado RIX4414 (Rotarix ™): a live attenuated human rotavirus vaccine
by: David I. Bernstein
Published: (2007-06-01)

Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia.
by: Katayi Mwila-Kazimbaya, et al.
Published: (2017-01-01)

Rotavirus cases among Rotarix vaccinated children below five years during the 2018 outbreak in the Kingdom of Eswatini
by: G. Maphalala
Published: (2020-12-01)

Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis
by: Htay Htay Han, et al.
Published: (2017-01-01)

Rotavirus A genotype G1P[8]: a novel method to distinguish wild-type strains from the Rotarix® vaccine strain
by: Tatiana L Rose, et al.
Published: (2010-12-01)

Effectiveness of Rotarix® vaccine in Africa in the first decade of progressive introduction, 2009-2019: systematic review and meta-analysis
by: Murunga, N, et al.
Published: (2020)

Immunogenicity, reactogenicity, and safety of a human rotavirus vaccine, Rotarix, in Taiwanese infants who received a dose of hepatitis B immunoglobulin after birth
by: Chun-Yi Lu, et al.
Published: (2013-09-01)

Rates of hospitalization and death for all-cause and rotavirus acute gastroenteritis before rotavirus vaccine introduction in Kenya, 2010–2013
by: Richard Omore, et al.
Published: (2019-01-01)

Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study
by: Paul Gillard, et al.
Published: (2019-04-01)

Rotavirus genotypes in Malaysia and universal rotavirus vaccination
by: Lee, Way Seah, et al.
Published: (2012)

Variation in rotavirus vaccine coverage by sub-counties in Kenya
by: Ernest Apondi Wandera, et al.
Published: (2017-04-01)

Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (Rotarix<sup>TM</sup>) Immunogenicity among Infants in Zambia
by: Adriace Chauwa, et al.
Published: (2023-07-01)

Evaluation of ROTARIX<sup>®</sup> Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial
by: Natasha Makabilo Laban, et al.
Published: (2023-02-01)

Differences in epidemiology of enteropathogens in children pre- and post-rotavirus vaccine introduction in Kilifi, coastal Kenya
by: Charles N. Agoti, et al.
Published: (2022-08-01)

Molecular Epidemiology of Rotavirus A Strains Pre- and Post-Vaccine (Rotarix<sup>®</sup>) Introduction in Mozambique, 2012–2019: Emergence of Genotypes G3P[4] and G3P[8]
by: Eva D. João, et al.
Published: (2020-08-01)

Cost-effectiveness of Rotavirus vaccination in Vietnam
by: Goldie Sue J, et al.
Published: (2009-01-01)

Cost-effectiveness of rotavirus vaccination in Turkey
by: Tulin Koksal, et al.
Published: (2017-10-01)

Rotaviruses and Rotavirus Vaccines
by: Celeste M. Donato, et al.
Published: (2021-07-01)

Molecular epideMiology of rotaviruses during rotavirus vaccine introduction in slovenia
by: Andrej Steyer, et al.
Published: (2009-08-01)

Prevalence of rotavirus infection among children with acute diarrhoea after rotavirus vaccine introduction in Kenya, a hospital cross-sectional study
by: Catherine Muendo, et al.
Published: (2018-10-01)

An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”
by: Tu Hong Anh T, et al.
Published: (2013-01-01)

Post-vaccine rotavirus genotype distribution in Nairobi County, Kenya
by: Joshua Ndung’u Gikonyo, et al.
Published: (2020-11-01)

Rotavirus vaccine introduction in Mexico sets precedent
by: Theresa Braine
Published: (2005-03-01)

Rotavirus epidemiology before and after vaccine introduction
by: Andrêssa S.F. Assis, et al.
Published: (2013-09-01)

Rotavirus epidemiology before and after vaccine introduction
by: Andrêssa S.F. Assis, et al.
Published: (2013-09-01)

Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial
by: Tamika Fellows, et al.
Published: (2023-08-01)